A new Covid-19 monoclonal antibody, 35B5, has the potential to neutralize all current and future SARS-CoV-2 variant strains.
A new Covid-19 monoclonal antibody, 35B5, has the potential to neutralize all current and future SARS-CoV-2 variant strains.